Correlation Between DiaMedica Therapeutics and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Tscan Therapeutics, you can compare the effects of market volatilities on DiaMedica Therapeutics and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Tscan Therapeutics.
Diversification Opportunities for DiaMedica Therapeutics and Tscan Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between DiaMedica and Tscan is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Tscan Therapeutics
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.11 times more return on investment than Tscan Therapeutics. However, DiaMedica Therapeutics is 1.11 times more volatile than Tscan Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 350.00 in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of 216.00 from holding DiaMedica Therapeutics or generate 61.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Tscan Therapeutics
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Tscan Therapeutics |
DiaMedica Therapeutics and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Tscan Therapeutics
The main advantage of trading using opposite DiaMedica Therapeutics and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Tscan Therapeutics vs. DiaMedica Therapeutics | Tscan Therapeutics vs. Lyra Therapeutics | Tscan Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |